Scientists investigated the effects of CD34+ cell therapy in patients with heart failure with preserved ejection fraction.
[European Journal of Heart Failure]
Home Newsletters Cell Therapy News A Pilot Clinical Trial of Cell Therapy in Heart Failure with Preserved...
